ADMA Biologics, Inc. | Johnson Fistel

ADMA Biologics, Inc. Class Action Lawsuit Alert: Johnson Fistel Notifies Investors of August 10, 2026 Lead Plaintiff Deadline

Johnson Fistel, PLLP, a shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors of ADMA Biologics, Inc. (“ADMA” or the “Company”) (NASDAQ: ADMA).

The ADMA class action lawsuit seeks to represent investors who purchased or otherwise acquired ADMA securities between August 9, 2024 and March 25, 2026, inclusive.

Investors are hereby notified that they have until August 10, 2026, to move the Court to serve as lead plaintiff in this action.

ADMA Investors: Contact Johnson Fistel

Name

This field is for validation purposes and should be left unchanged.

If you suffered a loss on your investment and would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. The information provided will be held in strict confidence unless and until you authorize us to disclose it.

Name(Required)

First Last

Email(Required)

Phone(Required)

Estimated Losses(Required)

Where did you see our press release?(Required)

If you selected 'Other' above, please specify below:(Required)

Would you like to receive future case and securities updates from Johnson Fistel, PLLP via email?(Required)

Yes

Would you like to receive information about Johnson Fistel, PLLP's free portfolio monitoring service?(Required)

Yes

By selecting yes, I agree to receive marketing text messages and calls from Johnson Fistel, PLLP at the phone number provided. I understand these messages may be sent using an automatic dialing system, that consent is not a condition of purchase or receipt of services, and that message & data rates may apply. I can reply HELP for help or STOP to cancel. See our Privacy Policy and Terms.(Required)

Yes

By checking the box, I acknowledge that this form is not intended to and does not establish an attorney-client relationship between myself and Johnson Fistel, PLLP, and that submission to or receipt of information from the firm or one of its attorneys via this form, website, email, or telephone does not create an attorney-client relationship.(Required)

I Agree

What Is the ADMA Class Action Lawsuit About?

The ADMA class action lawsuit alleges that defendants made false and/or misleading statements and/or failed to disclose material information regarding the Company’s business, revenue practices, related-party transactions, and internal controls.

According to the complaint, defendants allegedly failed to disclose that ADMA engaged in a related-party transaction. The complaint further alleges that the Company utilized channel stuffing to create the appearance of revenue and failed to maintain appropriate internal controls.

The complaint alleges that, as a result, ADMA’s public statements were false and materially misleading throughout the class period. When the market learned the truth about ADMA, investors allegedly suffered damages.

What Is a Lead Plaintiff?

A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. Investors do not need to serve as lead plaintiff in order to share in any potential future recovery.

The deadline for investors to seek appointment as lead plaintiff in the ADMA class action lawsuit is August 10, 2026.

About Johnson Fistel, PLLP

Johnson Fistel, PLLP is a nationally recognized shareholder rights law firm with offices in California, New York, Georgia, Idaho, and Colorado. The firm represents individual and institutional investors in shareholder class actions and derivative lawsuits.

Johnson Fistel has been selected as one of the Top 10 Plaintiff Law Firms by ISS Securities Class Action Services. In 2024, Johnson Fistel recovered approximately $90,725,000 for aggrieved investors.

Attorney advertising. Past results do not guarantee future outcomes. Services may be performed by attorneys in any of our offices.

This communication may be considered a promotional communication. Johnson Fistel, PLLP and its attorneys are responsible for the content of this communication. Frank J. Johnson is the attorney responsible for this advertisement.

Contact

Johnson Fistel, PLLP
501 W. Broadway, Suite 800
San Diego, CA 92101

James Baker, Investor Relations – or – Frank J. Johnson, Esq.
Phone: (619) 814-4471
Email: jimb@johnsonfistel.com | fjohnson@johnsonfistel.com